Intrust Bank’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $300K | Sell |
2,875
-218
| -7% | -$22.8K | 0.03% | 343 |
|
|
2025
Q1 | $361K | Buy |
3,093
+270
| +10% | +$31.5K | 0.04% | 295 |
|
|
2024
Q4 | $239K | Buy |
2,823
+183
| +7% | +$15.5K | 0.02% | 355 |
|
|
2024
Q3 | $237K | Sell |
2,640
-42
| -2% | -$3.78K | 0.02% | 362 |
|
|
2024
Q2 | $216K | Sell |
2,682
-258
| -9% | -$20.8K | 0.02% | 363 |
|
|
2024
Q1 | $235K | Buy |
2,940
+94
| +3% | +$7.5K | 0.03% | 364 |
|
|
2023
Q4 | $227K | Sell |
2,846
-350
| -11% | -$27.9K | 0.03% | 359 |
|
|
2023
Q3 | $223K | Buy |
3,196
+150
| +5% | +$10.5K | 0.03% | 346 |
|
|
2023
Q2 | $219K | Buy |
+3,046
| New | +$219K | 0.03% | 365 |
|
|
2023
Q1 | – | Sell |
-3,460
| Closed | -$267K | – | 394 |
|
|
2022
Q4 | $267K | Buy |
+3,460
| New | +$267K | 0.04% | 332 |
|